Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM

Table 1 Patients’ characteristics

n		87
age	years	65 (10)
diabetes duration	years	15 (8)
male : female	%	75 : 25
smoking ^§		38-47-15
body mass index	kg.m^-2	29.3 (5.9)
waist circumference	cm	104 (15)
metabolic syndrome	%	87
hypertension	%	91
anti-dyslipidemic drug(s)	%	90
statin-fibrate-ezetimibe	%	74-43-2
HbA _1c	mmol.mol^-1	62 (11)
glomerular filtration rate	mL.min^-11.73m²	80 (32)
albuminuria	μg.mg creatinine^-1	67 (126)
total cholesterol	mg.dL^-1	161 (35)
LDL-cholesterol	mg.dL^-1	80 (30)
non-HDL-cholesterol	mg.dL^-1	113 (36)
HDL-cholesterol	mg.dL^-1	49 (15)
apoB ₁₀₀	mg.dL^-1	81 (23)
estimated apoB₁₀₀ (equation 1)*	mg.dL^-1	80 (23)
estimated apoB₁₀₀ (equation 2)**	mg.dL^-1	80 (22)
triglycerides	mg.dL^-1	169 (105)
atherogenic dyslipidemia	%	49
coronary artery disease	%	25
peripheral artery disease	%	11
transient ischemic attack/stroke	%	5

Results are expressed as means (1 standard deviation) or proportions; apo, apolipoprotein; HbA_1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; §: never-former-current; * : equation 1: apoB₁₀₀(mg/dL) = [0.65 × non - HDL-cholesterol (mg/dL)] + 6.3 (mg/dL); * *: equation 2: apoB₁₀₀(mg/dL) = − 33.12 (mg/dL) + [0.675 × LDL-cholesterol (mg/dL)] + [11.95 × ln[triglycerides] (mg/dL)].

ISSN: 1475-2840